News

🔹 As of October 31, 2025, >10 pharmaceutical and medical device companies have successfully developed a new CSA template with the Hospital Authority (HA) covering 43 public hospitals. The progress is on good track and with a few more under negotiation.

🔹 GBAICTI will serve as a key contact to facilitate clinical research collaboration between the sponsors/CROs and the HA through providing constructive advices, e.g. ethics submission process under the harmonized scheme, standard CSA template development etc.

🔹 To facilitate smooth communication, enquiries can be directed to siteactivation@gbaicti.hk and we will assure to provide you with a timely response.

Many sponsors have already benefited from these streamlined processes, and more developments are on the horizon to further strengthen Hong Kong’s clinical research ecosystem. We appreciate the ongoing collaboration and look forward to streamlining site activation processes for all partners. Stay tuned for upcoming updates.